Navigation Links
Osteopal V

ProductsOsteopal V
Company Heraeus Medical
Item Osteopal V
Features Optimized viscosity for vertebroplasty, good mechanical properties, high X-ray contrast medium for optimal visualization and optimized handling time.
Description Osteopal V is a low viscosity bone cement, which has been developed for use in vertebroplasty. The bone cement is injected into the vertebral body lesion for stabilization purposes. Osteopal V is used for the augmentation of vertebral bodies. A high concentration of zirconium dioxide is included in the cement powder as an X-ray contrast medium. Indications for vertebroplasty: severely painful osteoporotic compression fractures, at painful vertebral body tumors (metastasis or myeloma), symptomatic vertebral hemangioma.

Distributed in the US by Zimmer.

Info Heraeus Medical
Customer Service: +44 (0) 1635 444 50
Web site: http://www.heraeus-medical.com

Related medicine products :

1. Codman Cervical Retractor
2. Codman Sofwire Cable System
3. Codman Anterior Cervical Plate Kit
4. Codmans Micro Osseous Dissection Curette
5. Codman-Cone Ring Curette
6. Codman Periosteal Elevators
7. Codman Hakim Programmable Valve (CHPV)
8. Codman Hakim Programmable Valve (CHPV) Cylindrical with Prechamber
9. Codman Hakim Programmable Valve (CHPV), Cylindrical
10. Codman Hakim Programmable Valve (CHPV) Micro
11. Codman Hakim Programmable Valve (CHPV) Micro with Rickham Reservoir
InterVascular HemaPatch product line offers the vascular surgeon a range of collagen coated patches in a range of larger sizes angioplasty, or profundaplasty procedures without suture hole bleeding. ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... is intended for use in the management of ... percutaneous catheters or tubes. The Pad is coated ... agent. Chitosan gel is twice as chemically active ... is derived. When placed over the puncture site, ...
The Sutura family of products is designed to allow interventionalists to perform vessel closure from 6F up to 24F. It's elegant design allows one-handed use through sheath, routinely eliminating need...
Medicine Products:
(Date:9/22/2017)... ... September 22, 2017 , ... ... tick-borne diseases through research, education and awareness, today announced the appointment of Timothy ... and microbiologist, Dr. Sellati has more than 20 years of research experience with ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      ... things wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create ... back to the community. For over 37 years, they have operated with their mission ... plumbing in San Diego. They were chosen as the Best San Diego plumber ...
(Date:9/21/2017)... Southborough, Mass. (PRWEB) , ... September 21, 2017 , ... ... for children with autism, announced today the election of Yie-Hsin Hung to the Board ... Yie-Hsin Hung join our Board of Directors. Ms. Hung is an invaluable addition to ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... 2017 Eli Lilly and Company (NYSE: ... data for galcanezumab and lasmiditan, two investigational treatments for ... Society (IHC) taking place Sept. 7-10 in ... new, long-term data from an open-label study evaluating the ... mg and 240 mg) for the prevention of migraine. ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: